LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 55.48 | 84.90 | 5621 | 6567 | 0.8558 | 0.9510 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 55.48 | 84.90 | 5351 | 6567 | 0.8147 | 0.9357 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 55.48 | 84.90 | 5369 | 6567 | 0.8175 | 0.9368 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 57.18 | 84.90 | 560 | 6963 | 0.0804 | 0.3454 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 57.18 | 84.90 | 5961 | 6963 | 0.8561 | 0.9517 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 57.18 | 84.90 | 5682 | 6963 | 0.8160 | 0.9370 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 57.18 | 84.90 | 5699 | 6963 | 0.8184 | 0.9380 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 58.88 | 84.90 | 500 | 7291 | 0.0686 | 0.3179 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 58.88 | 84.90 | 6298 | 7291 | 0.8637 | 0.9549 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 58.88 | 84.90 | 5876 | 7291 | 0.8058 | 0.9339 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 58.88 | 84.90 | 5892 | 7291 | 0.8080 | 0.9347 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 60.59 | 84.90 | 498 | 7641 | 0.0652 | 0.3133 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 60.59 | 84.90 | 6628 | 7641 | 0.8673 | 0.9566 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 60.59 | 84.90 | 6304 | 7641 | 0.8249 | 0.9416 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 60.59 | 84.90 | 6330 | 7641 | 0.8283 | 0.9428 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 62.29 | 84.90 | 589 | 7934 | 0.0742 | 0.3443 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 62.29 | 84.90 | 6943 | 7934 | 0.8750 | 0.9596 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 62.29 | 84.90 | 6517 | 7934 | 0.8214 | 0.9408 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 62.29 | 84.90 | 6548 | 7934 | 0.8253 | 0.9422 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 63.99 | 84.90 | 665 | 8212 | 0.0810 | 0.3662 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 63.99 | 84.90 | 7212 | 8212 | 0.8782 | 0.9610 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 63.99 | 84.90 | 6778 | 8212 | 0.8253 | 0.9426 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 63.99 | 84.90 | 6810 | 8212 | 0.8292 | 0.9440 | MN20160318_Q02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 65.70 | 84.90 | 593 | 8484 | 0.0699 | 0.3399 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 65.70 | 84.90 | 7457 | 8484 | 0.8789 | 0.9615 | MN20160318_Q02 | F19 |